The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary safety and efficacy of oral azacitidine (Oral-AZA) in patients (pts) with low-/Intermediate (Int)-risk myelodysplastic syndromes (MDS): Phase 2 results from the ASTREON trial.
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb/Celgene; Curis; Genentech; Gilead Sciences; Novartis
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb
Research Funding - Abbvie; Aprea Therapeutics; Astex Pharmaceuticals; Bristol-Myers Squibb; Curis; Genentech; Gilead Sciences; Novartis
 
Karen W. L. Yee
Honoraria - Amgen; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Amgen BioPharama; Bristol-Myers Squibb; GlaxoSmithKline; Jazz Pharmaceuticals; SERVIER; Shattuck Labs; Taiho Pharmaceutical
Research Funding - Astex Pharmaceuticals (Inst); F Hoffman - La Roche (Inst); Forma Therapeutics (Inst); Geron (Inst); Gilead Sciences (Inst); Hoffmann-la Roche Limited / Genentech (Inst); Inc Research (Inst); Karyopharm Therapeutics (Inst); LTD (Inst); Shattuck Labs (Inst); Treadwell Therapeutics (Inst)
 
Francisca Hernandez
No Relationships to Disclose
 
Matteo Giovanni Della Porta
No Relationships to Disclose
 
Stefania Paolini
No Relationships to Disclose
 
Seo-Yeon Ahn
No Relationships to Disclose
 
Valeria Santini
Honoraria - Celgene/Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Abbvie; Celgene/Bristol-Myers Squibb; CTI; Curis; Geron; Gilead Sciences; Novartis; Otsuka; SERVIER; Syros Pharmaceuticals
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Celgene; Janssen-Cilag
 
Pierre Fenaux
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
 
Takahiro Suzuki
Honoraria - Alexion Pharmaceuticals; Bristol-Myers Squibb Japan; Chugai Pharma; Kyowa Kirin; Nippon Shinyaku; Novartis; Otsuka
Consulting or Advisory Role - Alexion Pharmaceuticals; Bristol-Myers Squibb Japan
 
Mikkael A. Sekeres
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Kurome Therapeutics; Novartis; Syros Pharmaceuticals
Research Funding - Bristol-Myers Squibb (Inst); Rigel (Inst); Takeda (Inst)
 
Jun He
Employment - Bristol-Myers Squibb/Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Jerry Li
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Ronit Barkalifa
No Relationships to Disclose
 
Carlos E. Vigil
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Thomas Prebet
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Daniel Lopes de Menezes
Employment - Bristol Myers Squibb
Stock and Other Ownership Interests - Bristol Myers Squibb; Novartis
Patents, Royalties, Other Intellectual Property - Named on Patents at Novartis or named on Patents or filed/pending at Bristol Myers Squibb
 
Joseph Burnett
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Rami S. Komrokji
Stock and Other Ownership Interests - Abbvie
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; CTI BioPharma Corp; DSI; Geron; Gilead/Forty Seven; Jazz Pharmaceuticals; Novartis; Pharmaessentia; Sumitomo Pharma Oncology; Taiho Oncology; Takeda
Speakers' Bureau - Abbvie; CTI BioPharma Corp; Jazz Pharmaceuticals; Pharmaessentia; SERVIER
Research Funding - Bristol-Myers Squibb/Celgene (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Jazz Pharmaceuticals; Pharmaessentia
 
Aristoteles Giagounidis
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Geron